ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS
· Delayed Price · Currency is USD
9.35
-0.02 (-0.21%)
Mar 9, 2026, 3:24 PM EST
ZIVO Bioscience Revenue
ZIVO Bioscience had revenue of $65.63K in the quarter ending September 30, 2025, with 108.33% growth. This brings the company's revenue in the last twelve months to $209.03K, up 164.52% year-over-year. In the year 2024, ZIVO Bioscience had annual revenue of $157.22K with 468.61% growth.
Revenue (ttm)
209.03K
Revenue Growth
+164.52%
P/S Ratio
179.00
Revenue / Employee
29.86K
Employees
7
Market Cap
37.41M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionZIVO Bioscience News
- 6 months ago - ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses - Business Wire
- 9 months ago - ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO's Immune-Enhancing Compounds in Poultry - Business Wire
- 10 months ago - University of Delaware Study Identifies Optimal Formulation of ZIVO's Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry - Business Wire
- 1 year ago - ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry - Business Wire
- 1 year ago - ZIVO Bioscience to Present at The Microcap Conference 2025 - Business Wire
- 1 year ago - ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities - Business Wire
- 1 year ago - ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza - Business Wire
- 1 year ago - ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens - Business Wire